The objective of this project is to understand the molecular basis of the modulation of the gamma-aminobutyric acid(A) (GABA/A) receptor by the volatile anesthetics, enflurane, halothane and isoflurane, using the techniques of electrophysiology and molecular biology. The project proposes to first extend pharmacological studies of anesthetic modulation of the GABA(A) receptors of hippocampal neurons, in order to evaluate the hypothesis that there exists a correlation between anesthetic potency and drug potency for modulation of hippocampal GABA(A) receptors. Non- anesthetic compounds will also be tested. Single channel studies of the mechanisms of volatile anesthetic modulation of the GABA(A) receptor will also be performed. The GABA(A) receptor is a member of the 'family' of ligand-gated chloride channels. To begin to investigate the molecular basis of GABA(A) receptor modulation by volatile anesthetics, the effects of these agents will be studied on recombinant human GABA(A) receptors of known subunit composition. We will study heterooligomeric receptors of alpha/Beta, alpha/Beta/gamma, alpha/gamma and, if possible, homomeric receptors consisting of alpha subunits. In addition, the possible modulation by volatile anesthetics of other members of the ligand-gated chloride channel 'family', including the structurally related human glycine receptor, the human p1 subunit ('GABA(C) receptor') will be investigated, to determine whether all members of the ligand-gated chloride channel family are university modulated by volatile anesthetics, i.e., whether there are specific structural requirements for volatile anesthetic action at the GABA(A) receptor. Chimeric receptors will be constructed in order to gain further information about the nature of the sites for volatile anesthetic action on the human GABA(A) and glycine receptor subunits. Finally, more detailed information will be provided by using the techniques of site-directed mutagenesis to alter individual amino acid residues within the ligand-gated chloride channel subunits. Analysis of the molecular site of action of volatile anesthetics may lead to the development of anesthetic 'antagonists' which would be invaluable to clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM045129-07
Application #
2518966
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1991-09-01
Project End
1998-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
7
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Chicago
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Ying, Shui-Wang; Werner, David F; Homanics, Gregg E et al. (2009) Isoflurane modulates excitability in the mouse thalamus via GABA-dependent and GABA-independent mechanisms. Neuropharmacology 56:438-47
Belelli, Delia; Harrison, Neil L; Maguire, Jamie et al. (2009) Extrasynaptic GABAA receptors: form, pharmacology, and function. J Neurosci 29:12757-63
Castaldo, Pasqualina; Stefanoni, Patrizia; Miceli, Francesco et al. (2004) A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists. J Biol Chem 279:25598-604
Kash, Thomas L; Kim, Taeho; Trudell, James R et al. (2004) Evaluation of a proposed mechanism of ligand-gated ion channel activation in the GABAA and glycine receptors. Neurosci Lett 371:230-4
Zimmerman, S A; Jones, M V; Harrison, N L (1994) Potentiation of gamma-aminobutyric acidA receptor Cl- current correlates with in vivo anesthetic potency. J Pharmacol Exp Ther 270:987-91
Jones, M V; Harrison, N L (1993) Effects of volatile anesthetics on the kinetics of inhibitory postsynaptic currents in cultured rat hippocampal neurons. J Neurophysiol 70:1339-49
Harrison, N L; Kugler, J L; Jones, M V et al. (1993) Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane. Mol Pharmacol 44:628-32